Search

Your search keyword '"Bourdin, Arnaud"' showing total 64 results

Search Constraints

Start Over You searched for: Author "Bourdin, Arnaud" Remove constraint Author: "Bourdin, Arnaud" Database ScienceDirect Remove constraint Database: ScienceDirect
64 results on '"Bourdin, Arnaud"'

Search Results

3. CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma

4. Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma

6. Anti–IL-4R versus anti–IL-5/5R after anti–IL-5/5R failure in asthma: An emulated target trial

7. Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry

9. Global access and patient safety in the transition to environmentally friendly respiratory inhalers: the Global Initiative for Asthma perspective

11. Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry

12. French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2021 update. Full-length version

13. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

14. Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

17. Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases

18. Position paper of the French Society of Respiratory Diseases regarding pharmacological treatment optimization for stable COPD in 2021

19. Non-typeable Haemophilus influenzae–Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial

20. Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma

22. Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial

23. Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study

24. The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease

26. Defining a Severe Asthma Super-Responder: Findings from a Delphi Process

29. Prospective Multicenter Validation of the Detection of ALK Rearrangements of Circulating Tumor Cells for Noninvasive Longitudinal Management of Patients With Advanced NSCLC

30. Potential Severe Asthma Hidden in UK Primary Care

32. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

33. Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial

34. Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study

35. International Severe Asthma Registry: Mission Statement

38. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

Catalog

Books, media, physical & digital resources